MorganRosel Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-67
Closed -$1.85K 257
2025
Q2
$1.85K Hold
67
﹤0.01% 322
2025
Q1
$1.9K Buy
+67
New +$2.38K ﹤0.01% 313

Other funds holding MRNA

MorganRosel Wealth Management's MRNA Position: Q3 2025 in Review

MorganRosel Wealth Management sold out of Moderna (MRNA) in Q3 2025, closing a stake of 67 shares — an estimated $1.85K sold.

MorganRosel Wealth Management first reported a position in MRNA in Q1 2025 and held it in 2 quarters. The position peaked at $1.9K in Q1 2025. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • MorganRosel Wealth Management reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • MorganRosel Wealth Management sold 67 Moderna shares in Q3 2025, an estimated $1.85K.
  • MorganRosel Wealth Management first reported a position in Moderna in Q1 2025 and held it in 2 quarters.
  • MorganRosel Wealth Management's Moderna position peaked at $1.9K in Q1 2025.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on MorganRosel Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.